Go to
JCI Insight
Citations to this article
Kathryn V. Holmes
Published June 1, 2003
Citation Information: J Clin Invest. 2003;111(11):1605-1609. https://doi.org/10.1172/JCI18819.
Citation Information: J Clin Invest. 2003;111(11):1605-1609. https://doi.org/10.1172/JCI18819.
Total citations by year
Citation information
Citations to this article (209)
| Title and authors | Publication | Year |
|---|---|---|
|
The top 50 most-cited articles about COVID-19 and the complications of COVID-19: A bibliometric analysis
Singh T, Rao Padubidri J, Shetty PH, Antony Manoj M, Mary T, Thejaswi Pallempati B |
F1000Research | 2024 |
|
The top 50 most-cited articles about COVID-19 and the complications of COVID-19: A bibliometric analysis.
Singh T, Rao Padubidri J, Shetty PH, Antony Manoj M, Mary T, Thejaswi Pallempati B |
F1000Research | 2024 |
|
COVID-19 Vaccines and Assisted Reproductive Techniques: A Systematic Review.
Satorres-Pérez E, Martínez-Varea A, Morales-Roselló J |
Journal of Personalized Medicine | 2023 |
|
Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery.
Wright LR, Wright DL, Weller SK |
Viruses | 2022 |
|
Design and construction of a low cost air purifier for killing harmful airborne microorganisms using a combination of a strong multi-directional electric-field and an ultra violet light.
Ruwan Jayakantha DNP, Bandara HMN, Gunawardana NM, Jayantha Rajapakse RPV, Thilakarathne DS, Comini E, Gunawardhana N, Karunarathne SMML |
2022 | |
|
Inactivated vaccine injection and immunoglobulin G levels related to severe coronavirus disease 2019 (Delta) pneumonia in Xi'an, China: A single-centered, retrospective, observational study.
Yang H, Ma J, Li A, Lei J, Shang F, Cheng Y, Han B, Li H, Chen Y, Yang Y, Xu Y |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination.
Chua JX, Durrant LG, Chok YL, Lai OM |
iScience | 2022 |
|
Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease.
Babu G, Nobel FA |
Informatics in medicine unlocked | 2022 |
|
Oligomerization-Dependent Beta-Structure Formation in SARS-CoV-2 Envelope Protein.
Surya W, Torres J |
International journal of molecular sciences | 2022 |
|
Enhanced Framework for COVID-19 Prediction with Computed Tomography Scan Images using Dense Convolutional Neural Network and Novel Loss Function.
Motwani A, Shukla PK, Pawar M, Kumar M, Ghosh U, Numay WA, Nayak SR |
2022 | |
|
SARS-CoV-2 accessory protein 7b forms homotetramers in detergent.
Surya W, Queralt-Martin M, Mu Y, Aguilella VM, Torres J |
Virology Journal | 2022 |
|
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
KY Oguntuyo, CS Stevens, CT Hung, S Ikegame, JA Acklin, SS Kowdle, JC Carmichael, HP Chiu, KD Azarm, GD Haas, F Amanat, J Klingler, I Baine, S Arinsburg, JC Bandres, MN Siddiquey, RM Schilke, MD Woolard, H Zhang, AJ Duty, TA Kraus, TM Moran, D Tortorella, JK Lim, AV Gamarnik, CE Hioe, S Zolla-Pazner, SS Ivanov, JP Kamil, F Krammer, B Lee, K Subbarao |
mBio | 2021 |
|
Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment
M Blanch-Ruiz, R Ortega-Luna, G Gómez-García, M Martínez-Cuesta, Á Álvarez |
Biomedicines | 2021 |
|
Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
AO Shalash, WM Hussein, M Skwarczynski, I Toth |
Advanced Science | 2021 |
|
The Covid-19 vs Globe : Turn Disaster Into Opportunity
R Kanungo, DK Nama |
2021 | |
|
Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 vs. SARS-CoV and RaTG13
Z Li, JZ Zhang |
Physical Chemistry Chemical Physics | 2021 |
|
Coronavirus disease 2019 and its potential animal reservoirs: A review
S Islam, FM Hasib, C Nath, J Ara, MS Nu, A Fazal, S Chowdhury |
International Journal of One Health | 2021 |
|
Drug Discovery and Treatment of an Emerging Pandemic Infection Covid-19
A MİSHRA, P MİSHRA, R DAS |
2021 | |
|
Importance of Genetic Engineering and Gene Therapy in the Management of Viral Diseases and Outbreaks
V Arora, A Aggarwal, S Aggarwal, R Kumar |
2021 | |
|
Full autopsy in a confirmed COVID-19 patient in Lagos, Nigeria – A case report
SO Keshinro, NA Awolola, LA Adebayo, WB Mutiu, BA Saka, IA Abdus-Salam |
Human Pathology: Case Reports | 2021 |
|
Peptide Platform as a Powerful Tool in the Fight against COVID-19
M Murdocca, G Citro, I Romeo, A Lupia, S Miersch, B Amadio, A Bonomo, A Rossi, SS Sidhu, PP Pandolfi, S Alcaro, FC Sangiuolo, G Novelli |
Viruses | 2021 |
|
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies
A Khursheed, V Jain, A Rasool, MA Rather, NA Malik, AH Shalla |
Microbial Pathogenesis | 2021 |
|
Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection
M Dioguardi, AP Cazzolla, C Arena, D Sovereto, GA Caloro, A Dioguardi, V Crincoli, L Laino, G Troiano, LL Muzio |
Pediatric reports | 2021 |
|
Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings
P Avti, A Chauhan, N Shekhar, M Prajapat, P Sarma, H Kaur, A Bhattacharyya, S Kumar, A Prakash, S Sharma, B Medhi |
Journal of Biomolecular Structure and Dynamics | 2021 |
|
Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection
BK Park, D Kim, S Park, S Maharjan, J Kim, JK Choi, M Akauliya, Y Lee, HJ Kwon |
Biomolecules and Therapeutics | 2021 |
|
Pan-coronavirus fusion inhibitors as the hope for today and tomorrow
X Wang, S Xia, Y Zhu, L Lu, S Jiang |
Protein & Cell | 2021 |
|
Deep dorsal penile vein thrombosis in a patient with COVID-19 infection: A rare complication and the first reported case.
Bagheri SM, Tabrizi Z |
Clinical Case Reports | 2021 |
|
Human Body Performance with COVID-19 Affectation According to Virus Specification Based on Biosensor Techniques.
Alathari MJA, Al Mashhadany Y, Mokhtar MHH, Burham N, Bin Zan MSD, A Bakar AA, Arsad N |
Sensors (Basel, Switzerland) | 2021 |
|
Extrapulmonary manifestations of COVID-19.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW |
Nature Medicine | 2020 |
|
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Shahrajabian MH, Sun W, Cheng Q |
Human Vaccines & Immunotherapeutics | 2020 |
|
COVID-19 infection: origin, transmission, and characteristics of human coronaviruses
MA Shereen, S Khan, A Kazmi, N Bashir, R Siddique |
Journal of Advanced Research | 2020 |
|
Emerging pharmacotherapies for COVID-19
R Salvi, P Patankar |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2020 |
|
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
MH Shahrajabian, W Sun, Q Cheng |
Human Vaccines & Immunotherapeutics | 2020 |
|
Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations
J Zou, J Yin, L Fang, M Yang, T Wang, W Wu, MA Bellucci, P Zhang |
Journal of Chemical Information and Modeling | 2020 |
|
Introduction - Emerging Pathogens and the COVID-19 Pandemic
RB McFee |
Disease-a-month : DM | 2020 |
|
Extrapulmonary manifestations of COVID-19
A Gupta, MV Madhavan, K Sehgal, N Nair, S Mahajan, TS Sehrawat, B Bikdeli, N Ahluwalia, JC Ausiello, EY Wan, DE Freedberg, AJ Kirtane, SA Parikh, MS Maurer, AS Nordvig, D Accili, JM Bathon, S Mohan, KA Bauer, MB Leon, HM Krumholz, N Uriel, MR Mehra, MS Elkind, GW Stone, A Schwartz, DD Ho, JP Bilezikian, DW Landry |
Nature Medicine | 2020 |
|
Drug targets for COVID-19 therapeutics: Ongoing global efforts
A Saxena |
Journal of Biosciences | 2020 |
|
Transplant Drugs against SARS, MERS and COVID-19
R Hage, C Steinack, F Gautschi, MM Schuurmans |
2020 | |
|
Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)
RB McFee |
Disease-a-month : DM | 2020 |
|
The Viral Etiologies of Severe Acute Respiratory Infection: Indian Perspective on the Emerging Pathogens
T Shaw, VA Indumathi |
2020 | |
|
Therapeutic Targets and Computational Approaches on Drug Development for COVID-19
A Shanmugam, N Muralidharan, D Velmurugan, MM Gromiha |
Current topics in medicinal chemistry | 2020 |
|
Human pathogen coronaviruses – An overview
RB McFee |
Disease-a-month : DM | 2020 |
|
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
M Fani, A Teimoori, S Ghafari |
Future Virology | 2020 |
|
COVID-19: An Appeal for an Intersectoral Approach to Tackle With the Emergency
A Scagliarini, A Alberti |
Frontiers in public health | 2020 |
|
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
JS Morse, T Lalonde, S Xu, WR Liu |
Chembiochem : a European journal of chemical biology | 2020 |
|
COVID-19 therapy: What weapons do we bring into battle?
SM de Almeida, JC Soares, KL dos Santos, JE Alves, AG Ribeiro, ÍT Jacob, CJ da Silva Ferreira, JC dos Santos, JF de Oliveira, LB de Carvalho Junior, M do Carmo Alves de Lima |
Bioorganic & Medicinal Chemistry | 2020 |
|
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
R Mirzaei, R Mohammadzadeh, F Mahdavi, F Badrzadeh, S Kazemi, M Ebrahimi, F Soltani, S Kazemi, AS Jeda, M Darvishmotevalli, R Yousefimashouf, H Keyvani, S Karampoor |
International Immunopharmacology | 2020 |
|
Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya
D Onchonga, J Omwoyo, D Nyamamba |
Saudi Pharmaceutical Journal | 2020 |
|
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
D Yesudhas, A Srivastava, MM Gromiha |
Infection | 2020 |
|
Coronavirus in human diseases: Mechanisms and advances in clinical treatment
P Lin, M Wang, Y Wei, T Kim, X Wei |
2020 | |
|
COVID-19 associated variations in liver function parameters: a retrospective study
RK Saini, N Saini, S Ram, SL Soni, V Suri, P Malhotra, J Kaur, I Verma, S Sharma, D Zohmangaihi |
Postgraduate medical journal | 2020 |
|
Virucidal benefits of povidone-iodine use on the ocular surface: a review
M Edington, K Ramaesh, D Lockington |
2020 | |
|
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
Morse JS, Lalonde T, Xu S, Liu WR |
Chembiochem : a European journal of chemical biology | 2020 |
|
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R |
Journal of Advanced Research | 2020 |
|
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
Morse JS, Lalonde T, Xu S, Liu W |
ChemRxiv : the preprint server for chemistry | 2020 |
|
COVID-19: An Appeal for an Intersectoral Approach to Tackle With the Emergency.
Scagliarini A, Alberti A |
Frontiers in public health | 2020 |
|
Emerging pharmacotherapies for COVID-19.
Salvi R, Patankar P |
Biomedicine & Pharmacotherapy | 2020 |
|
Introduction - Emerging Pathogens and the COVID-19 Pandemic.
McFee RB |
Disease-a-month : DM | 2020 |
|
Human pathogen coronaviruses - An overview.
McFee RB |
Disease-a-month : DM | 2020 |
|
Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.
Zou J, Yin J, Fang L, Yang M, Wang T, Wu W, Bellucci MA, Zhang P |
Journal of Chemical Information and Modeling | 2020 |
|
Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV).
McFee RB |
Disease-a-month : DM | 2020 |
|
Drug targets for COVID-19 therapeutics: Ongoing global efforts.
Saxena A |
Journal of Biosciences | 2020 |
|
Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera
Oguntuyo KY, Stevens CS, Hung CT, Ikegame S, Acklin JA, Kowdle SS, Carmichael JC, Chiu HP, Azarm KD, Haas GD, Amanat F, Klingler J, Baine I, Arinsburg S, Bandres JC, Siddiquey MN, Schilke RM, Woolard MD, Zhang H, Duty AJ, Kraus TA, Moran TM, Tortorella D, Lim JK, Gamarnik AV, Hioe CE, Zolla-Pazner S, Ivanov SS, Kamil JP, Krammer F, Lee B |
2020 | |
|
A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic.
Onchonga D |
2020 | |
|
Exploiting the unique features of Zika and Dengue proteases for inhibitor design
T Majerová, P Novotný, E Krýsová, J Konvalinka |
Biochimie | 2019 |
|
An alignment-free method for bulk comparison of protein sequences from different species
B Dogan |
2019 | |
|
Structural model of the SARS coronavirus E channel in LMPG micelles
W Surya, Y Li, J Torres |
Biochimica et Biophysica Acta (BBA) - Biomembranes | 2018 |
|
Production of a Monoclonal Antibody Targeting the M Protein of MERS-CoV for Detection of MERS-CoV Using a Synthetic Peptide Epitope Formulated with a CpG–DNA–Liposome Complex
BK Park, SI Lee, JY Bae, MS Park, Y Lee, HJ Kwon |
International Journal of Peptide Research and Therapeutics | 2018 |
|
Virus Protein and Nucleoprotein Complexes
JR Harris, D Bhella |
2018 | |
|
Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins.
To J, Torres J |
Sub-cellular biochemistry | 2018 |
|
Surface Plasmon Resonance: A Boon for Viral Diagnostics
Singh P |
Reference Module in Life Sciences | 2018 |
|
Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors
JY Park, HJ Yuk, HW Ryu, SH Lim, KS Kim, KH Park, YB Ryu, WS Lee |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2017 |
|
Reference Module in Life Sciences
D Hartmann, H Friess |
Reference Module in Life Sciences | 2017 |
|
EMERGING RESPIRATORY DISEASE - CORONAVIRUSES.
|
Disease-a-month : DM | 2017 |
|
Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches
Adhikari N, Baidya SK, Saha A, Jha T |
Viral Proteases and Their Inhibitors | 2017 |
|
Advances in Protein Chemistry and Structural Biology
J To, W Surya, J Torres |
Advances in protein chemistry and structural biology | 2016 |
|
The prevalence, origin, and prevention of six human coronaviruses
L Liu, T Wang, J Lu |
Virologica Sinica | 2016 |
|
Channel-Inactivating Mutations and Their Revertant Mutants in the Envelope Protein of Infectious Bronchitis Virus
J To, W Surya, TS Fung, Y Li, C Verdià-Bàguena, M Queralt-Martin, VM Aguilella, DX Liu, J Torres, S Perlman |
Journal of virology | 2016 |
|
Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?
J Torres, W Surya, Y Li, D Liu |
Viruses | 2015 |
|
Betacoronavirus 1 in alpacas (Vicugna pacos) in the High Peruvian Andes
L Luna, PE Brandão, L Maturrano, R Rosadio, FD Silva, RM Soares, F Gregori |
Small Ruminant Research | 2015 |
|
Betacoronavirus 1 in alpacas (Vicugna pacos) in the High Peruvian Andes.
Luna L, Brandão PE, Maturrano L, Rosadio R, Silva FDF, Soares RM, Gregori F |
2015 | |
|
Human Respiratory Viral Infections
TM Mak, R Lin, YJ Tan |
Human Respiratory Viral Infections | 2014 |
|
BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface
SM Wang, KJ Huang, CT Wang |
Virology | 2014 |
|
Atlas of coronavirus replicase structure
BW Neuman, P Chamberlain, F Bowden, J Joseph |
Virus Research | 2014 |
|
From SARS coronavirus to novel animal and human coronaviruses
KK To, IF Hung, JF Chan, KY Yuen |
Journal of Thoracic Disease | 2013 |
|
A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes
XW Zhang |
Computational Biology and Chemistry | 2013 |
|
Viral Infections and Global Change: Singh/Viral Infections and Global Change
KM Carbone, JC de la Torre |
Viral Infections and Global Change: Singh/Viral Infections and Global Change | 2013 |
|
BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface.
Wang SM, Huang KJ, Wang CT |
Virology | 2013 |
|
Advances in Applied Microbiology
JL Brooks, KK Jefferson |
Advances in applied microbiology | 2012 |
|
Understanding Viral Transmission Behavior via Protein Intrinsic Disorder Prediction: Coronaviruses
GK Goh, AK Dunker, VN Uversky |
Journal of Pathogens | 2012 |
|
Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication
CC Wen, LF Shyur, JT Jan, PH Liang, CJ Kuo, P Arulselvan, JB Wu, SC Kuo, NS Yang |
Journal of traditional and complementary medicine | 2011 |
|
Study on the Fast Killing of Harmful Microorganisms in Air Space Using Z Zhang, M Bai, X Yang, N Zhang |
IEEE Transactions on Plasma Science | 2011 |
|
Software Tools and Algorithms for Biological Systems
HR Arabnia, QN Tran |
2011 | |
|
Structural Considerations in the Fitness Landscape of a Virus
T Watabe, H Kishino |
Molecular Biology and Evolution | 2010 |
|
Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies
YT Fang, CF Lin, PC Liao, YM Kuo, S Wang, TM Yeh, CC Shieh, IJ Su, HY Lei, YS Lin |
Molecular Immunology | 2010 |
|
Identification of SARS-COV Spike Protein-Derived and HLA-A2-Restricted Human CTL Epitopes by Using a New Muramyl Dipeptide-Derivative Adjuvant
YZ Chen, G Liu, S Senju, Q Wang, A Irie, M Haruta, M Matsui, F Yasui, M Kohara, Y Nishimura |
International journal of immunopathology and pharmacology | 2010 |
|
Structural considerations in the fitness landscape of a virus.
Watabe T, Kishino H |
Molecular Biology and Evolution | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
SARS vaccines: where are we?
RL Roper, KE Rehm |
Expert Review of Vaccines | 2009 |
|
Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening
X Zhang, J Wang, K Wen, Z Mou, L Zou, X Che, B Ni, Y Wu |
Viral Immunology | 2009 |
|
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
L Du, Y He, Y Zhou, S Liu, BJ Zheng, S Jiang |
Nature Reviews Microbiology | 2009 |
|
Epigenetic mechanisms in human adenovirus type 12 oncogenesis
W Doerfler |
Seminars in Cancer Biology | 2009 |
|
Molecular Biology of the SARS-Coronavirus
SK Lal |
2009 | |
|
Programmed –1 Ribosomal Frameshifting in SARS Coronavirus
Dinman JD |
2009 | |
|
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
RH See, M Petric, DJ Lawrence, CP Mok, T Rowe, LA Zitzow, KP Karunakaran, TG Voss, RC Brunham, J Gauldie, BB Finlay, RL Roper |
Journal of General Virology | 2008 |
|
Experimental Studies on Elimination of Microbial Contamination by Hydroxyl Radicals Produced by Strong Ionization Discharge
B Mindong, Z Zhitao, Z Dongyan, Y Bo |
Plasma Science and Technology | 2008 |
|
Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses
M Liniger, A Zuniga, A Tamin, TN Azzouz-Morin, M Knuchel, RR Marty, M Wiegand, S Weibel, D Kelvin, PA Rota, HY Naim |
Vaccine | 2008 |
|
SARS- and Other Coronaviruses
D Cavanagh |
2008 | |
|
Exploring the Roles and Nature of Science: A case study of severe acute respiratory syndrome
YC Lee |
International Journal of Science Education | 2008 |
|
Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein
F Pacciarini, S Ghezzi, F Canducci, A Sims, M Sampaolo, E Ferioli, M Clementi, G Poli, PG Conaldi, R Baric, E Vicenzi |
Journal of virology | 2008 |
|
Pathogen surveillance through monitoring of sewer systems.
Sinclair RG, Choi CY, Riley MR, Gerba CP |
Advances in applied microbiology | 2008 |
|
Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope
YK Cheung, SC Cheng, FW Sin, KT Chan, Y Xie |
Vaccine | 2007 |
|
Analysis of proteins that interact with nucleocapsid protein of SARS-CoV using 15-mer phage-displayed library
ZX Liu, ZH Wang, YL Liu, W Dong, YP Qi |
Chinese Science Bulletin | 2007 |
|
Duration of antibody responses after severe acute respiratory syndrome
LP Wu, NC Wang, YH Chang, XY Tian, DY Na, LY Zhang, L Zheng, T Lan, LF Wang, GD Liang |
Emerging infectious diseases | 2007 |
|
SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era
G Zhao |
Philosophical transactions of the Royal Society of London. Series B, Biological sciences | 2007 |
|
Comparison of effectiveness of whole viral, N and N199 proteins by ELISA for the rapid diagnosis of severe acute respiratory syndrome coronavirus:
Z GUO, J LU, W HAN, Z LIU, G LI, J LIAO, S WANG, Y WU, H ZHENG, N ZHONG, X ZHU |
Chinese Medical Journal | 2007 |
|
Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin
K Padhan, C Tanwar, A Hussain, PY Hui, MY Lee, CY Cheung, JS Peiris, S Jameel |
Journal of General Virology | 2007 |
|
Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus
CC Wen, YH Kuo, JT Jan, PH Liang, SY Wang, HG Liu, CK Lee, ST Chang, CJ Kuo, SS Lee, CC Hou, PW Hsiao, SC Chien, LF Shyur, NS Yang |
Journal of Medicinal Chemistry | 2007 |
|
Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
A Roberts, J Wood, K Subbarao, M Ferguson, D Wood, T Cherian |
Vaccine | 2006 |
|
Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions
W Li, SK Wong, F Li, JH Kuhn, IC Huang, H Choe, M Farzan |
Journal of virology | 2006 |
|
Cynomolgus macaque as an animal model for severe acute respiratory syndrome
JV Lawler, TP Endy, LE Hensley, A Garrison, EA Fritz, M Lesar, RS Baric, DA Kulesh, DA Norwood, LP Wasieloski, MP Ulrich, TR Slezak, E Vitalis, JW Huggins, PB Jahrling, J Paragas |
PLoS Medicine | 2006 |
|
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV
M Maache, F Komurian-Pradel, A Rajoharison, M Perret, JL Berland, S Pouzol, A Bagnaud, B Duverger, J Xu, A Osuna, G Paranhos-Baccalà |
Clinical and vaccine immunology : CVI | 2006 |
|
Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS
JM Nicholls, J Butany, LL Poon, KH Chan, SL Beh, S Poutanen, JS Peiris, M Wong |
PLoS Medicine | 2006 |
|
Detection of feline coronavirus using microcantilever sensors
S Velanki, HF Ji |
Measurement Science and Technology | 2006 |
|
Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention
KS Yeung, GA Yamanaka, NA Meanwell |
Medicinal Research Reviews | 2006 |
|
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
K Ishii, H Hasegawa, N Nagata, T Mizutani, S Morikawa, T Suzuki, F Taguchi, M Tashiro, T Takemori, T Miyamura, Y Tsunetsugu-Yokota |
Virology | 2006 |
|
Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus
B Tripet, DJ Kao, SA Jeffers, KV Holmes, RS Hodges |
Journal of Structural Biology | 2006 |
|
Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R
WC Hwang, Y Lin, E Santelli, J Sui, L Jaroszewski, B Stec, M Farzan, WA Marasco, RC Liddington |
The Journal of biological chemistry | 2006 |
|
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.
Zhang L, Zhang F, Yu W, He T, Yu J, Yi CE, Ba L, Li W, Farzan M, Chen Z, Yuen KY, Ho D |
Journal of Medical Virology | 2006 |
|
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.
Liu W, Fontanet A, Zhang PH, Zhan L, Xin ZT, Baril L, Tang F, Lv H, Cao WC |
The Journal of Infectious Diseases | 2006 |
|
Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
Yeung KS, Yamanaka GA, Meanwell NA |
Medicinal Research Reviews | 2006 |
|
Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK.
Roberts A, Wood J, Subbarao K, Ferguson M, Wood D, Cherian T |
Vaccine | 2006 |
|
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
Tong TR |
Perspectives in Medical Virology | 2006 |
|
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.
Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y |
Virology | 2006 |
|
Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC |
The Journal of biological chemistry | 2006 |
|
Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity
YS Lin, CF Lin, YT Fang, YM Kuo, PC Liao, TM Yeh, KY Hwa, CC Shieh, JH Yen, HJ Wang, IJ Su, HY Lei |
Clinical & Experimental Immunology | 2005 |
|
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus
SR Weiss, S Navas-Martin |
Microbiology and molecular biology reviews : MMBR | 2005 |
|
Multiple organ infection and the pathogenesis of SARS
J Gu, E Gong, B Zhang, J Zheng, Z Gao, Y Zhong, W Zou, J Zhan, S Wang, Z Xie, H Zhuang, B Wu, H Zhong, H Shao, W Fang, D Gao, F Pei, X Li, Z He, D Xu, X Shi, VM Anderson, AS Leong |
Journal of Experimental Medicine | 2005 |
|
Biochip sensors for the rapid and sensitive detection of viral disease
AD Livingston, CJ Campbell, EK Wagner, P Ghazal |
Genome biology | 2005 |
|
The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein
YJ Tan |
Virology Journal | 2005 |
|
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
T Li, Y Zhang, L Fu, C Yu, X Li, Y Li, X Zhang, Z Rong, Y Wang, H Ning, R Liang, W Chen, LA Babiuk, Z Chang |
Gene Therapy | 2005 |
|
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates
D Pinna, A Sampson-Johannes, M Clementi, G Poli, S Rossini, L Lin, E Vicenzi |
Transfusion Medicine | 2005 |
|
Patient satisfaction with doctor-patient interaction in a radiotherapy centre during the severe acute respiratory syndrome outbreak
JI Tang, TP Shakespeare, XJ Zhang, JJ Lu, S Liang, CJ Wynne, RK Mukherjee, MF Back |
Australasian Radiology | 2005 |
|
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
L Zhang, F Zhang, W Yu, T He, J Yu, CE Yi, L Ba, W Li, M Farzan, Z Chen, KY Yuen, D Ho |
Journal of Medical Virology | 2005 |
|
Vaccine Design for Severe Acute Respiratory Syndrome Coronavirus
Y He, S Jiang |
Viral Immunology | 2005 |
|
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein
Y Zhi, GP Kobinger, H Jordan, K Suchma, SR Weiss, H Shen, G Schumer, G Gao, JL Boyer, RG Crystal, JM Wilson |
Virology | 2005 |
|
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
Y He, Q Zhu, S Liu, Y Zhou, B Yang, J Li, S Jiang |
Virology | 2005 |
|
Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique1
S CHEN, L CHEN, H LUO, T SUN, J CHEN, F YE, J CAI, J SHEN, X SHEN, H JIANG |
Acta Pharmacologica Sinica | 2005 |
|
Characterization of viral proteins encoded by the SARS-coronavirus genome
YJ Tan, SG Lim, W Hong |
Antiviral Research | 2005 |
|
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
J Zhou, W Wang, Q Zhong, W Hou, Z Yang, SY Xiao, R Zhu, Z Tang, Y Wang, Q Xian, H Tang, L Wen |
Vaccine | 2005 |
|
SARS-coronavirus replication in human peripheral monocytes/macrophages
M Yilla, BH Harcourt, CJ Hickman, M McGrew, A Tamin, CS Goldsmith, WJ Bellini, LJ Anderson |
Virus Research | 2005 |
|
Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays
WF Kuang, LP Chow, MH Wu, LH Hwang |
Biochemical and Biophysical Research Communications | 2005 |
|
A human SARS-CoV neutralizing antibody against epitope on S2 protein
J Duan, X Yan, X Guo, W Cao, W Han, C Qi, J Feng, D Yang, G Gao, G Jin |
Biochemical and Biophysical Research Communications | 2005 |
|
Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus
MJ Gubbins, FA Plummer, XY Yuan, D Johnstone, M Drebot, M Andonova, A Andonov, JD Berry |
Molecular Immunology | 2005 |
|
Inhalation Toxicology, Second Edition: Natural and Deliberate
J Mann, N Connell |
Inhalation Toxicology, Second Edition: Natural and Deliberate | 2005 |
|
Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
Ken Yan Ching Chow, Chung Chau Hon, Raymond Kin Hi Hui, Raymond Tsz Yeung Wong, Chi Wai Yip, Fanya Zeng, Frederick Chi Ching Leung |
Genomics, proteomics & bioinformatics / Beijing Genomics Institute | 2005 |
|
The epitope study on the SARS-CoV nucleocapsid protein
Shuting Li, Liang Lin, Hao Wang, Jianning Yin, Yan Ren, Zhe Zhao, Jie Wen, Cuiqi Zhou, Xumin Zhang, Xiaolei Li, Jingqiang Wang, Zhengfeng Zhou, Jinxiu Liu, Jianmin Shao, Tingting Lei, Jianqiu Fang, Ningzhi Xu, Siqi Liu |
Genomics, proteomics & bioinformatics / Beijing Genomics Institute | 2005 |
|
Multiple organ infection and the pathogenesis of SARS
J Gu, E Gong, B Zhang, J Zheng, Z Gao, Y Zhong, W Zou, J Zhan, S Wang, Z Xie, H Zhuang, B Wu, H Zhong, H Shao, W Fang, D Gao, F Pei, X Li, Z He, D Xu, X Shi, VM Anderson, AS Leong |
Journal of Experimental Medicine | 2005 |
|
Critical Assessment of Important Regions in the Subunit Association and Catalytic Action of the Severe Acute Respiratory Syndrome Coronavirus Main Protease
WC Hsu, HC Chang, CY Chou, PJ Tsai, PI Lin, GG Chang |
The Journal of biological chemistry | 2005 |
|
Isolation of avian infectious bronchitis coronavirus from domestic peafowl (Pavo cristatus) and teal (Anas)
S Liu, J Chen, J Chen, X Kong, Y Shao, Z Han, L Feng, X Cai, S Gu, M Liu |
Journal of General Virology | 2005 |
|
Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus
EN van den Brink, J ter Meulen, F Cox, MA Jongeneelen, A Thijsse, M Throsby, WE Marissen, PM Rood, AB Bakker, HR Gelderblom, BE Martina, AD Osterhaus, W Preiser, HW Doerr, J de Kruif, J Goudsmit |
Journal of virology | 2005 |
|
Civets Are Equally Susceptible to Experimental Infection by Two Different Severe Acute Respiratory Syndrome Coronavirus Isolates
D Wu, C Tu, C Xin, H Xuan, Q Meng, Y Liu, Y Yu, Y Guan, Y Jiang, X Yin, G Crameri, M Wang, C Li, S Liu, M Liao, L Feng, H Xiang, J Sun, J Chen, Y Sun, S Gu, N Liu, D Fu, BT Eaton, LF Wang, X Kong |
Journal of virology | 2005 |
|
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies
M Faber, EW Lamirande, A Roberts, AB Rice, H Koprowski, B Dietzschold, MJ Schnell |
Journal of General Virology | 2005 |
|
Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies
Y He, H Lu, P Siddiqui, Y Zhou, S Jiang |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
|
Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S, Chen LL, Luo HB, Sun T, Chen J, Ye F, Cai JH, Shen JK, Shen X, Jiang HL |
Acta Pharmacologica Sinica | 2005 |
|
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S |
Virology | 2005 |
|
Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.
Hsu WC, Chang HC, Chou CY, Tsai PJ, Lin PI, Chang GG |
The Journal of biological chemistry | 2005 |
|
Patient satisfaction with doctor-patient interaction in a radiotherapy centre during the severe acute respiratory syndrome outbreak.
Tang JI, Shakespeare TP, Zhang XJ, Lu JJ, Liang S, Wynne CJ, Mukherjee RK, Back MF |
Australasian Radiology | 2005 |
|
Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes
Nathalie Macours, Jeroen Poels, Korneel Hens, Carmen Francis, Roger Huybrechts |
International Review of Cytology | 2004 |
|
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus
TW Kim, JH Lee, CF Hung, S Peng, R Roden, MC Wang, R Viscidi, YC Tsai, L He, PJ Chen, DA Boyd, TC Wu |
Journal of virology | 2004 |
|
Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site
E Lontok, E Corse, CE Machamer |
Journal of virology | 2004 |
|
Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis
ZF Sun, XJ Meng |
Journal of clinical microbiology | 2004 |
|
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht, A Roberts, L Vogel, A Bukreyev, PL Collins, BR Murphy, K Subbarao, B Moss |
Proceedings of the National Academy of Sciences | 2004 |
|
Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus
L Lu, I Manopo, BP Leung, HH Chng, AE Ling, LL Chee, EE Ooi, SW Chan, J Kwang |
Journal of clinical microbiology | 2004 |
|
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao, J McAuliffe, L Vogel, G Fahle, S Fischer, K Tatti, M Packard, WJ Shieh, S Zaki, B Murphy |
Journal of virology | 2004 |
|
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
J Sui, W Li, A Murakami, A Tamin, LJ Matthews, SK Wong, MJ Moore, AS Tallarico, M Olurinde, H Choe, LJ Anderson, WJ Bellini, M Farzan, WA Marasco |
Proceedings of the National Academy of Sciences | 2004 |
|
Novel and re-emerging respiratory infections
NJ Snell |
Expert Review of Anti-infective Therapy | 2004 |
|
Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus in Pneumocytes of the Lung
KC Chow, CH Hsiao, TY Lin, CL Chen, SH Chiou |
American Journal of Clinical Pathology | 2004 |
|
SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation
C Sylvester-Hvid, M Nielsen, K Lamberth, G Roder, S Justesen, C Lundegaard, P Worning, H Thomadsen, O Lund, S Brunak, S Buus |
Tissue Antigens | 2004 |
|
Handbook of Laboratory Animal Science, Second Edition: Animal Models, Volume III
R Helm |
Handbook of Laboratory Animal Science, Second Edition: Animal Models, Volume III | 2004 |
|
The aetiology, origins, and diagnosis of severe acute respiratory syndrome
LL Poon, Y Guan, JM Nicholls, KY Yuen, JS Peiris |
The Lancet Infectious Diseases | 2004 |
|
The weapon potential of a microbe
A Casadevall, L Pirofski |
Trends in Microbiology | 2004 |
|
SARS: future research and vaccine
YL Lau |
Paediatric Respiratory Reviews | 2004 |
|
2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents
PW Hsieh, FR Chang, CH Chang, PW Cheng, LC Chiang, FL Zeng, KH Lin, YC Wu |
Bioorganic & Medicinal Chemistry Letters | 2004 |
|
Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59
LB Thackray, KV Holmes |
Virology | 2004 |
|
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
E Mortola, P Roy |
FEBS Letters | 2004 |
|
Severe acute respiratory syndrome and tuberculosis
RA Stackhouse |
Anesthesiology Clinics of North America | 2004 |
|
Coronaviridae and SARS-associated Coronavirus Strain HSR1
E Vicenzi, F Canducci, D Pinna, N Mancini, S Carletti, A Lazzarin, C Bordignon, G Poli, M Clementi |
Emerging infectious diseases | 2004 |
|
Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection
A Berger, C Drosten, HW Doerr, M Stürmer, W Preiser |
Journal of Clinical Virology | 2004 |
|
Lupus pneumonitis or severe acute respiratory syndrome?
CC Mok, KY Ying |
Lupus | 2004 |
|
Detection of Severe Acute Respiratory Syndrome–Associated Coronavirus in Pneumocytes of the Lung
KC Chow, CH Hsiao, TY Lin, CL Chen, SH Chiou |
American Journal of Clinical Pathology | 2004 |
|
Das SARS-assoziierte Coronavirus – Die erste Pandemie des 21. Jahrhunderts / The SARS-associated coronavirus – The first pandemic of the 21st century
A Berger, C Drosten, HW Doerr, W Preiser |
LaboratoriumsMedizin | 2004 |
|
Quaternary Structure of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Main Protease
CY Chou, HC Chang, WC Hsu, TZ Lin, CH Lin, GG Chang |
Biochemistry | 2004 |
|
Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines
Y He, Y Zhou, H Wu, B Luo, J Chen, W Li, S Jiang |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
|
Severe acute respiratory syndrome
JS Peiris, Y Guan, KY Yuen |
Nature Medicine | 2004 |
|
A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan
YH Wang, AS Lin, TY Chao, SN Lu, JW Liu, SS Chen, MC Lin |
Intensive Care Medicine | 2004 |
|
Serology of severe acute respiratory syndrome: implications for surveillance and outcome.
Chen X, Zhou B, Li M, Liang X, Wang H, Yang G, Wang H, Le X |
The Journal of Infectious Diseases | 2004 |
|
SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.
Sylvester-Hvid C, Nielsen M, Lamberth K, Røder G, Justesen S, Lundegaard C, Worning P, Thomadsen H, Lund O, Brunak S, Buus S |
Tissue Antigens | 2004 |
|
Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein.
Yao YX, Ren J, Heinen P, Zambon M, Jones IM |
The Journal of Infectious Diseases | 2004 |
|
Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus.
Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC |
The Journal of Infectious Diseases | 2004 |
|
Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.
Berger A, Drosten Ch, Doerr HW, Stürmer M, Preiser W |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2004 |
|
Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus
H Sun, H Luo, C Yu, T Sun, J Chen, S Peng, J Qin, J Shen, Y Yang, Y Xie, K Chen, Y Wang, X Shen, H Jiang |
Protein Expression and Purification | 2003 |
|
SARS: una nueva enfermedad desenmascarada
AP Bezares, MT Mateos |
Atención Primaria | 2003 |
|
Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
KY Chow, CC Hon, RK Hui, RT Wong, CW Yip, F Zeng, FC Leung |
Genomics Proteomics & Bioinformatics | 2003 |
|
The Epitope Study on the SARS-CoV Nucleocapsid Protein
S Li, L Lin, H Wang, J Yin, Y Ren, Z Zhao, J Wen, C Zhou, X Zhang, X Li, J Wang, Z Zhou, J Liu, J Shao, T Lei, J Fang, N Xu, S Liu |
Genomics Proteomics & Bioinformatics | 2003 |
|
Human Immunodeficiency Virus Hematology
PA Volberding, KR Baker, AM Levine |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2003 |
|
The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5′ to 3′ Viral Helicases
JA Tanner, RM Watt, YB Chai, LY Lu, MC Lin, JS Peiris, LL Poon, HF Kung, JD Huang |
The Journal of biological chemistry | 2003 |
|
The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.
Tanner JA, Watt RM, Chai YB, Lu LY, Lin MC, Peiris JS, Poon LL, Kung HF, Huang JD |
The Journal of biological chemistry | 2003 |
|
[SARS: a new illness unmasked].
Pareja Bezares A, Torán Mateos M |
2003 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)